Ann-mari M. Svennerholm

Goeteborg, O 45030, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

ETVAX: From Concepts to Demonstrated Clinical Efficacy.

ETVAX: From Concepts to Demonstrated Clinical Efficacy.

Journal: Microorganisms

Published: May 12, 2026

The case for evaluation of double mutant heat-labile toxin as an adjuvant to improve oral cholera vaccine immunogenicity.

The case for evaluation of double mutant heat-labile toxin as an adjuvant to improve oral cholera vaccine immunogenicity.

Journal: Frontiers in immunology

Published: February 07, 2026

Efficacy of ETVAX, a vaccine against enterotoxigenic Escherichia coli-positive diarrhoea in Gambian children: a double-blind, randomised, placebo-controlled, phase 2b trial.

Efficacy of ETVAX, a vaccine against enterotoxigenic Escherichia coli-positive diarrhoea in Gambian children: a double-blind, randomised, placebo-controlled, phase 2b trial.

Journal: The Lancet. Infectious diseases

Published: September 15, 2025

Colonization factors of human and animal-specific enterotoxigenic Escherichia coli (ETEC): (Trends in Microbiology, 32:5 p:448-464, 2024).

Colonization factors of human and animal-specific enterotoxigenic Escherichia coli (ETEC): (Trends in Microbiology, 32:5 p:448-464, 2024).

Journal: Trends in microbiology

Published: April 10, 2025

Use of a TaqMan Array Card for identification of enterotoxins and colonization factors directly from stool samples in an enterotoxigenic E. coli vaccine study.

Use of a TaqMan Array Card for identification of enterotoxins and colonization factors directly from stool samples in an enterotoxigenic E. coli vaccine study.

Journal: Microbiology spectrum

Published: February 11, 2025

The Incidence and Risk Factors for Enterotoxigenic E. coli Diarrheal Disease in Children under Three Years Old in Lusaka, Zambia.

The Incidence and Risk Factors for Enterotoxigenic E. coli Diarrheal Disease in Children under Three Years Old in Lusaka, Zambia.

Journal: Microorganisms

Published: January 19, 2024

A Perspective on the Strategy for Advancing ETVAX®, An Anti-ETEC Diarrheal Disease Vaccine, into a Field Efficacy Trial in Gambian Children: Rationale, Challenges, Lessons Learned, and Future Directions.

A Perspective on the Strategy for Advancing ETVAX®, An Anti-ETEC Diarrheal Disease Vaccine, into a Field Efficacy Trial in Gambian Children: Rationale, Challenges, Lessons Learned, and Future Directions.

Journal: Microorganisms

Published: November 15, 2023

Efficacy of an Enterotoxigenic Escherichia coli (ETEC) Vaccine on the Incidence and Severity of Traveler's Diarrhea (TD): Evaluation of Alternative Endpoints and a TD Severity Score.

Efficacy of an Enterotoxigenic Escherichia coli (ETEC) Vaccine on the Incidence and Severity of Traveler's Diarrhea (TD): Evaluation of Alternative Endpoints and a TD Severity Score.

Journal: Microorganisms

Published: August 12, 2023

Colonization factors of human and animal-specific enterotoxigenic Escherichia coli (ETEC).

Colonization factors of human and animal-specific enterotoxigenic Escherichia coli (ETEC).

Journal: Trends in microbiology

Published: July 11, 2023

Safety, tolerability, and immunogenicity of an oral inactivated ETEC vaccine (ETVAX®) with dmLT adjuvant in healthy adults and children in Zambia: An age descending randomised, placebo-controlled trial.

Safety, tolerability, and immunogenicity of an oral inactivated ETEC vaccine (ETVAX®) with dmLT adjuvant in healthy adults and children in Zambia: An age descending randomised, placebo-controlled trial.

Journal: Vaccine

Published: February 13, 2023

Developments in oral enterotoxigenic Escherichia coli vaccines.

Developments in oral enterotoxigenic Escherichia coli vaccines.

Journal: Current opinion in immunology

Published: February 03, 2023

Safety and immunogenicity of ETVAX®, an oral inactivated vaccine against enterotoxigenic Escherichia coli diarrhoea: a double-blinded, randomized, placebo-controlled trial amongst Finnish travellers to Benin, West Africa.

Safety and immunogenicity of ETVAX®, an oral inactivated vaccine against enterotoxigenic Escherichia coli diarrhoea: a double-blinded, randomized, placebo-controlled trial amongst Finnish travellers to Benin, West Africa.

Journal: Journal of travel medicine

Published: January 05, 2023

Showing 1-12 of 66

Last Updated: 09/26/2026